Cost-effectiveness of recombinant versus urinary follicle stimulating hormone; whose point of view?
Ola
B
B
Assisted Conception Unit, Birmingham Women's Hospital, Edgbaston, Birmingham, B15 2TG, UK. bolarinde.ola@bham-womens.thenhs.com
Afnan
M
M
Sharif
K
K
Hammadieh
N
N
Papaioannou
S
S
Coomarasamy
A
A
D000328:Adult; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D005260:Female; D005307:Fertilization in Vitro / Q000191:economics*; D005640:Follicle Stimulating Hormone / Q000191:economics*; D006801:Humans; D011994:Recombinant Proteins / Q000191:economics
D011994:Recombinant Proteins; D005640:Follicle Stimulating Hormone